Journal for ImmunoTherapy of Cancer

Thanks to the opportunity as ambassadors from Society for Immunotherapy of Cancer (SITC) & Journal for ImmunoTherapy of Cancer to expand influence in Asia, we just successfully wrapped up World Immunotherapy Council (WIC) Asian Chapter meeting in Shanghai. This is coorganising with Tongji University @Pulmonary Hospital (who have world largest number of lung surgery per year), China Society of Immunology & China Society of Clinical Oncology (CSCO). Thrilled to see speakers & hundreds of attendees across Asia to gather in the main conference and series of satelite meeting to discuss the advances & future of Cancer Immunology / Immuno-oncology in Asia. stay tuned for next year events across Asia (at least Singapore & China), from WIC Asia, to entire Asia. :) #immunotherapy #spatial #immunopathology #AI #CSCO #immunology #oncology A*STAR - Agency for Science, Technology and Research Singapore General Hospital Han Chong Toh Daniel SW Tan Melvin L.K. Chua Joline Lim Raghav Sundar MBBS, PhD Bernard A. Fox PhD Michael Lotze Rom Leidner Jian Han Zihai Li, MD, PhD Jerome Galon Nattiya Hirankarn, MD, PhD James Gulley MD PhD FACP 周彩存Caicun Ji Hongbin Zhaodong Li Steve Mao

New #JITC article: Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells https://bit.ly/3VLm7fu Winship Cancer Institute of Emory University

New #JITC article: Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis https://bit.ly/3VKrU56

New #JITC article: Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma https://bit.ly/4eEojxS Clinical Cancer Institute of Nanjing University, Nanjing, China

六月28-29 浦东香格里拉 如果对肿瘤免疫治疗有兴趣的师兄弟姐妹们还请参加哦。会议是免费的。这是我们SITC( 全球肿瘤免疫治疗大会 Society for Immunotherapy of Cancer (SITC)）第一次在亚洲办会。主席 James Gulley MD PhD FACP, 以及大会下属杂志JITC (影响因子11分, Journal for ImmunoTherapy of Cancer）总编辑 Michael Lotze 也会到场。不容错过喔。：） 今年很高兴我与Bernard A. Fox PhD 作为创始人 创立了World ImmunoTherapy Council Asian Chapter, 聚集了大于10个国家与地区的肿瘤免疫组织。接下来的几年还请大家关注我们。 PS:// 疫情后俺终于有机会回上海了。来去匆匆，若能见个面叙旧几句 还请告知。：） “If you speak/read chinese, pls share the above to your China contacts"." Exciting news for all immunotherapy enthusiasts! 🌟 The first Society for Immunotherapy of Cancer (SITC) (SITC) official event is coming to Asia (next year will be in Singapore) for the first time, taking place on June 28-29th 2024 at SHANGHAI Pudong Shangri-La Shangri-La Group. 🌏 Don't miss this incredible opportunity to join in-coming President James Gulley MD PhD FACP and JITC Editor-in-Chief Michael Lotze at this groundbreaking event. Best of all, attendance is free! Additionally, the establishment of the World ImmunoTherapy Council Asian Chapter is a significant milestone (co-founded by Bernard A. Fox PhD and me, Joe YEONG 杨宝诚), gathering tumor immunology organizations from over 10 countries and regions. 🤝 Keep a lookout for the impactful work we'll be doing together in the coming years. PS:// Thrilled to be back in Shanghai post-epidemic! If you're around and up for a quick catch-up, I'd love to connect. Let me know! 🇨🇳 #Immunotherapy #CancerResearch #GlobalHealth #Networking #Shanghai #SITCConference #JITC #Collaboration #Singapore

New #JITC article: Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy https://bit.ly/3KXcRzV. Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China

Looking forward to the future of IO treatment, #JITC Editor-in-Chief Dr. Michael Lotze and Deputy Editor-in-Chief Prof. Sjoerd van der Burg share their perspectives on the future of the field and the journal’s role in advancing it. #CIM24 https://lnkd.in/gveyAiGF 

SITC is pleased to announce the publication of a new manuscript titled, “Challenges and Opportunities in Cancer Immunotherapy: A Society for Immunotherapy of Cancer (SITC) Strategic Vision” available now in the Journal for ImmunoTherapy of Cancer. https://lnkd.in/gezZeD-X #JITC #SpecialSeries

New #JITC position article and guidelines - Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision https://bit.ly/4evIXAp #CIM24 Authors: Leisha Emens, Pedro Romero, Ana Anderson, Tullia Bruno, Christian M Capitini, Deborah Collyar, James Gulley, Patrick Hwu, Avery Posey, Jr., Ann W. Silk, Jennifer A Wargo

The June #JITC Digest is out! Read a recent editorial from Editor-in-Chief Michael T. Lotze, MD and understand JITC's role in accelerating scientific advancement. Access position papers and guidelines to enhance clinical decision making in the field. Read a recent editorial from Editor-in-Chief Michael T. Lotze, MD and understand JITC's role. Celebrate Cancer Immunotherapy Month with Society for Immunotherapy of Cancer (SITC) and discover educational and development opportunities offered by the society. View June Digest: https://ow.ly/QPyl50SmpEi